Ascendis Pharma A/S (ASND) has 3 SEC Form 4 insider filings on record in the last 90 days. That includes 1 insider purchase totalling $493K, and 1 sales totalling $62K. Most recent filing: Sept. 9, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 9, 2026 filed Sept. 8, 2026 | Bodenhoff Mads SVP & PAO | $480,570 | 9,000 | 0% | No | |
|
|
||||||
| Sept. 3, 2026 filed Sept. 2, 2026 | HOLTUG LARS Director | −$62,335 | 236 | −6% | No | |
|
|
||||||
| Aug. 18, 2026 filed Aug. 14, 2026 | BIENAIME JEAN JACQUES Director | +$492,654 | 2,000 | +222% | No | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free